Project Grant R03AG097747
Award Date 9/22/25
Completion Date 8/31/27
Dollars Obligated $224K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nigeria
Similar Awards
- This Cooperative Agreement awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $487,582 to characterize the burden of cerebral small vessel disease (SVD) in a population-based indigenous African cohort in Nigeria. The project, titled "Cerebral Small Vessel Disease and Brain Health in an Indigenous African Cohort (CSVD-IAC)", aims to: Test the relationship between MRI-based SVD metrics and retinal imaging metrics to determine thresholds for...
- This $4,444,978 federal Project Grant award, issued by the National Institute on Aging (CFDA 93.866 Aging Research program), supports research to characterize cognitive reserve and identify modifiable factors that promote cognitive reserve and resilience to Alzheimer's disease and related dementias (ADRD) among older adults in India, with a focus on those who lack formal education. The project aims to: 1) compare brain pathology measures and their contributions to cognition between older...
- The National Institute on Aging (NIA) awarded a $455,035 Cooperative Agreement through its Aging Research Federal Grant Program (CFDA 93.866) to the Trustees of Boston University to establish an Alzheimer's disease and related dementias (AD/ADRD) research infrastructure in resource-limited areas of Africa. The 2-year UG3 exploratory/development phase aims to foster a research consortium co-led by three Africa-based teams in Ghana, Tanzania, and the Republic of the Congo, supported by Boston...
- This $215,509 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop infrastructure for aging and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) research in Botswana. The key products and services to be delivered under this 2-year award include: Leveraging Botswana's 2022 census data to develop a sampling frame and study design for population-based aging and AD/ADRD research in Botswana. This will enable accurate and...
- This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $1,550,462 to support a 5-year cross-sectional, longitudinal, and observational study investigating the impact of Alzheimer's disease (AD) risk genes, with a focus on APOE E4, on brain function in older Black/African American individuals living with HIV. The project aims to enroll 120 participants with HIV (60 with and 60 without the APOE E4 allele) and 80 demographically...
- This $2,288,528 federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to improve cross-national measurement of mild cognitive impairment (MCI) and characterize its longitudinal course across diverse populations in the U.S., Mexico, and India. The study will harmonize MCI and dementia diagnoses, compare MCI prognosis, and investigate sociodemographic, lifestyle, health, and biological risk factors associated with MCI and dementia across...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $163,080 to The University of Texas Health Science Center at San Antonio to conduct research aimed at addressing critical knowledge gaps in the use of plasma biomarkers for Alzheimer's disease and related dementias. The key objectives are to: 1) Identify demographic, lifestyle, genetic, and systemic disease factors associated with elevated plasma biomarkers in population cohorts in the U.S....
- This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- This federal Project Grant award of $2,528,708.00 was provided by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), to the University of Alabama at Birmingham (UAB). The funding will support research to examine the timecourse and consequences of undiagnosed Alzheimer's disease and related dementias (ADRD) across the United States. The project aims to augment Medicare claims data with cognitive assessment data from the Reasons for Geographic...